Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Lang

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 25, 2023
Choosing Wisely in allergy and clinical immunology: The first decadeDavid M Lang
Allergy and Asthma Proceedings|October 29, 2025
Management of chronic urticaria: Treatment options when omalizumab failsDavid M Lang
Annals of the American Thoracic Society|October 29, 2013
Multimorbidity: the new normalDavid M Lang
Allergy and Asthma Proceedings|January 18, 2014
Evidence-based diagnosis and treatment of chronic urticaria/angioedemaDavid M Lang
Clinical Reviews in Allergy & Immunology|October 28, 2005
Asthma deaths and the athleteDavid M Lang
Allergy and Asthma Proceedings|January 19, 2008
An overview of EPR3 asthma guidelines: what's different?David M Lang
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2014
A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedemaDavid M Lang
Allergy and Asthma Proceedings|November 5, 2015
Severe asthma: epidemiology, burden of illness, and heterogeneityDavid M Lang
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 20, 2015
Quality measures in allergy, asthma, and immunologyChitra Dinakar, David M Lang
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
Once You Label Me…John Oppenheimer, David M Lang
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 25, 2023
Choosing Wisely in allergy and clinical immunology: The first decadeDavid M Lang
Allergy and Asthma Proceedings|October 29, 2025
Management of chronic urticaria: Treatment options when omalizumab failsDavid M Lang
Annals of the American Thoracic Society|October 29, 2013
Multimorbidity: the new normalDavid M Lang
Allergy and Asthma Proceedings|January 18, 2014
Evidence-based diagnosis and treatment of chronic urticaria/angioedemaDavid M Lang
Clinical Reviews in Allergy & Immunology|October 28, 2005
Asthma deaths and the athleteDavid M Lang
Allergy and Asthma Proceedings|January 19, 2008
An overview of EPR3 asthma guidelines: what's different?David M Lang
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2014
A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedemaDavid M Lang
Allergy and Asthma Proceedings|November 5, 2015
Severe asthma: epidemiology, burden of illness, and heterogeneityDavid M Lang
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 20, 2015
Quality measures in allergy, asthma, and immunologyChitra Dinakar, David M Lang
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
Once You Label Me…John Oppenheimer, David M Lang
Pageof 14